ClinicalTrials.gg
CompletedNCT06786702Updated Nov 17, 2026

The Importance of Preserving the Round Ligament in the Repair of Inguinal Hernias in Women

An interventional study of Laparoscopic TAPP (Trans Abdominal Pre-Peritoneal) hernia repair: Round Ligament Preservation and Laparoscopic TAPP (Trans Abdominal Pre-Peritoneal) hernia repair: Round Ligament Cutting in Inguinal Hernia, Femoral Hernia and Obturator Hernia, sponsored by Muhammet Mustafa Vural. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Muhammet Mustafa Vural · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled May 2024, registered Aug 2024).
Updated Nov 17, 2026Now CompletedStart date moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 77 studies in Hernia, Inguinal with a site in Turkey — 12 open to participants now, 14 under way, none of them phase 3. Hernia, Inguinal · Turkey.

Enrollment
18th of 60
90 · median 80
Started
2024
with 4 others
No phase
52 of 77
11 open now
Registered
51st of 77
by date

Among the 77 studies in Hernia, Inguinal with a site in Turkey, this one is the 18th largest by enrollment of the 60 interventional ones that give a count, is one of 5 that started in 2024, is one of 52 with no phase, and was the 51st registered.

Hernia, Inguinal

545 studies on the registry are indexed under Hernia, Inguinal; 91 are open to participants now.

Browse Hernia, Inguinal studies →

Open to participants now

12 of the 77 studies in Hernia, Inguinal with a site in Turkey are open now. Recruiting first, the newest first:

7 more — sign in →

All 12 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 54 Hernia, Inguinal studies recruiting now, 30 (56%) set no upper age limit and 16 (30%) stop at 75 or younger; 16 take children under 18; 9 take healthy volunteers.

This study: 18 Years to 70 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 77 studies in Hernia, Inguinal with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study is to evaluate the impact of preserving or not preserving the round ligament during laparoscopic Trans Abdominal Pre-Peritoneal (TAPP) hernia repair on postoperative outcomes in female patients. Specifically, the study will compare outcomes such as postoperative pain, seroma, hematoma, uterine prolapse, recurrence rates, and quality of life between patients whose round ligament was preserved versus those whose ligament was cut.

Read the detailed description

Study Overview:

The aim of this study is to evaluate the impact of preserving or not preserving the round ligament during laparoscopic Trans Abdominal Pre-Peritoneal (TAPP) hernia repair on postoperative outcomes in female patients. Specifically, the study will compare outcomes such as postoperative pain, seroma, hematoma, uterine prolapse, recurrence rates, and quality of life between patients whose round ligament was preserved versus those whose ligament was cut.

Background:

In women, inguinal hernias are less common but can present as femoral, inguinal, or obturator hernias. Treatment usually involves surgical repair, which can be performed using open or laparoscopic techniques. Laparoscopic methods, especially TAPP and Total Extraperitoneal (TEP), are increasingly preferred due to their lower recurrence rates and other benefits compared to open surgery.

Advantages of Laparoscopic TAPP Surgery:

Small Incisions: Results in less risk of complications and cosmetic benefits. Bilateral Viewing: Allows visualization and treatment of both sides simultaneously.

Lower Infection Risk: Smaller incisions reduce the risk of infection. Faster Recovery: Less postoperative pain and quicker return to daily activities.

Reduced Recurrence: More effective in preventing recurrence, especially after an initial open surgery.

Round Ligament Considerations:

The round ligament connects the uterus to the labia majora and can be involved in the TAPP procedure. The debate centers on whether to preserve or cut the round ligament during surgery. Preservation can be technically challenging due to adhesions, but cutting the ligament might impact recurrence rates and patient outcomes negatively.

There is ongoing debate about whether to preserve or cut the round ligament during laparoscopic preperitoneal repair in female patients. Many surgeons express concerns that preserving the round ligament may increase the risk of hernia recurrence. A recent study encompassing 1,365 women who underwent various methods of inguinal hernia repair (open, laparoscopic, or robotic) found that in 868 cases (63.6%) , the round ligament was cut. This suggests that in practice, round ligament division is commonly performed during both open and laparoscopic procedures.

However, literature indicates that there are few studies with weak evidence suggesting that not preserving the round ligament may lead to issues such as pain, dyspareunia (pain during intercourse), organ prolapse, and decreased quality of life.

Study Objectives:

Compare Outcomes: Assess the effects of preserving versus cutting the round ligament on postoperative pain, hernia recurrence, and quality of life.

Prospective Analysis: Collect and analyze data prospectively to determine the optimal surgical approach.

Conclusion:

This study aims to provide insights into the optimal surgical technique for female inguinal hernia repair using TAPP, highlighting the importance of round ligament management and its impact on patient outcomes.

03

Conditions studied

  • Inguinal Hernia
  • Femoral Hernia
  • Obturator Hernia

Browse trials for

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • For patients applying to the General Surgery Clinic of Basaksehir Cam Sakura City Hospital:
  • Age Range: Female patients aged between 18 and 70 years.
  • Type of Hernia: Patients with inguinal, direct or indirect, femoral, and obturator hernias.
  • Surgical Indication: Patients indicated for TAPP (Transabdominal Preperitoneal) surgery.
  • Consent: Patients who consent to participate in the study.
  • General Anesthesia: Patients who are suitable for general anesthesia.
  • Follow-up: Patients who attend follow-up appointments regularly.

Exclusion criteria

Exclusion Criteria:

  • Age: Female patients under 18 years old or over 70 years old.
  • Surgical Technique: Patients who are operated on with techniques other than TAPP (e.g., TEP, conventional surgery).
  • Hernia Type: Patients with strangulated or incarcerated hernias.
  • Hernia Location: Patients with hernias outside the groin region.
  • Surgical Site: Surgeries performed in different clinics.
  • Gender: Male patients.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
90 participants (actual)

Study arms

  • Active comparator
    Group 1 (Round Ligament Preservation)

    Patients will undergo laparoscopic TAPP surgery with the round ligament preserved. The preservation will be achieved using a longitudinal incision technique in the peritoneum.

    Procedure: Laparoscopic TAPP (Trans Abdominal Pre-Peritoneal) hernia repair: Round Ligament Preservation · Device: Polypropylene mesh

  • Active comparator
    Group 2 (Round Ligament Cutting)

    Patients will undergo laparoscopic TAPP surgery with the round ligament cut close to the peritoneum using an energy device.

    Procedure: Laparoscopic TAPP (Trans Abdominal Pre-Peritoneal) hernia repair: Round Ligament Cutting · Device: Polypropylene mesh

Interventions

  • ProcedureLaparoscopic TAPP (Trans Abdominal Pre-Peritoneal) hernia repair: Round Ligament Preservation

    Group 1 (Round Ligament Preservation): Patients will undergo laparoscopic TAPP surgery with the round ligament preserved. The preservation will be achieved using a longitudinal incision technique in the peritoneum.

  • ProcedureLaparoscopic TAPP (Trans Abdominal Pre-Peritoneal) hernia repair: Round Ligament Cutting

    Group 2 (Round Ligament Cutting): Patients will undergo laparoscopic TAPP surgery with the round ligament cut close to the peritoneum using an energy device.

  • DevicePolypropylene mesh

    Polypropylene mesh of at least 10 x 15 cm placed in the preperitoneal space to cover the myopectineal orifice and fixed with tackers (two to Cooper's ligament and one lateral to the rectus muscle). Used identically in both arms; it is not the intervention of interest.

06

What researchers measure

Primary outcomes

  1. Postoperative Complication

    "Number of Participants with Postoperative Complications : Seroma (in centimeters) , Hematoma (in centimeters) , Loss of Sensation on Neurological Examination , Prolapse (in centimeters) Numbness (reported in anamnesis), Tingling (reported in anamnesis), Urinary Retention (reported in anamnesis), Dyspareunia (reported in anamnesis) . Measured at Day 1, Month 3, and Year 1"

    Time frame: 1 years

Secondary outcomes

  1. Duration of Operation (in minutes)

    Outcome Description: The total duration of the surgical operation, measured in minutes, recorded during the operation.

    Time frame: During the index operation (intraoperative)

  2. Blood Loss During Operation (in milliliters)

    Outcome Description: The amount of blood loss recorded during the operation, measured in milliliters.

    Time frame: During the index operation (intraoperative)

  3. Number of Tackers Used During Operation

    Outcome Description: The total number of tackers used during the operation.

    Time frame: During the index operation (intraoperative)

  4. Mesh Size Used in Operation (in square centimeters)

    Outcome Description: The size of the mesh used during the operation, measured in square centimeters.

    Time frame: During the index operation (intraoperative)

  5. Pain Score at the Hernia Side (Using EuraHS-QoL)

    Pain in the hernia area assessed with the pain domain of the European Registry for Abdominal Wall Hernias Quality of Life score (EuraHS-QoL): 3 items (pain at rest, pain during activities, worst pain in the past week), each scored 0-10; domain score range 0-30. Higher scores indicate a worse outcome (more pain).

    Time frame: Measurements will be conducted on Day 1, at Month 3, and at Year 1

  6. Score for Activity Limitation Due to Pain or Discomfort (Using EuraHS-QoL)

    Restriction of activities due to pain or discomfort in the hernia area, assessed with the restriction domain of the European Registry for Abdominal Wall Hernias Quality of Life score (EuraHS-QoL): 4 items (daily activities inside the house, outside the house, during sports, during heavy labour), each scored 0-10; domain score range 0-40. Higher scores indicate a worse outcome (more restriction).

    Time frame: Measurements will be conducted on Day 1, at Month 3, and at Year 1

  7. Cosmetic Discomfort Score (Using EuraHS-QoL)

    Cosmetic discomfort assessed with the cosmetic domain of the European Registry for Abdominal Wall Hernias Quality of Life score (EuraHS-QoL): 2 items (shape of the abdomen, appearance of the hernia site), each scored 0-10; domain score range 0-20. Higher scores indicate a worse outcome (more cosmetic discomfort).

    Time frame: Measurements will be conducted on Day 1, at Month 3, and at Year 1

07

Study locations

1 site
08

References and documents

Publications

  • Renshaw S, Collins C, Gupta A, Poulose B, Haisley KR. Round Ligament Management in Female Patients Undergoing Inguinal Hernia Repair: Should We Divide or Preserve? J Am Coll Surg. 2022 Jun 1;234(6):1193-1200. doi: 10.1097/XCS.0000000000000207. Epub 2022 Apr 8. PubMed 35703818 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2024 to primary completion in Jul 2026, 26 months.

Of 179 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's 26 months is above that.

Counting every sponsor, half of 188 studies reached it within 19 months; a quarter within 9 and three quarters within 36.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 17, 2026: start Apr 2024 → May 2024, primary completion Apr 2025 → Jul 2026 and completion Apr 2026 → Jul 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 18, 2024
First posted
Jan 22, 2025
StartActual
May 1, 2024was Apr 2024
Primary completionActual
Jul 3, 2026was Apr 2025
CompletionActual
Jul 3, 2026was Apr 2026
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 17, 2026
Start date
Apr 20, 2024→May 1, 2024
Nov 17, 2026
Primary completion
Apr 30, 2025→Jul 3, 2026 (actual)
Nov 17, 2026
Study completion
Apr 20, 2026→Jul 3, 2026 (actual)
Nov 17, 2026
Enrollment
106 (estimated)→90 (actual)
Nov 17, 2026
Interventions
Added Device: Polypropylene mesh
Nov 17, 2026
Secondary outcomes
4 time frame changed, 3 description edited
What changed in the outcomes
  • Time frameDuration of Operation (in minutes)Per-operation → During the index operation (intraoperative)
  • Time frameBlood Loss During Operation (in milliliters)Per-operation → During the index operation (intraoperative)
  • Time frameNumber of Tackers Used During OperationPer-operation → During the index operation (intraoperative)
  • Time frameMesh Size Used in Operation (in square centimeters)Per-operation → During the index operation (intraoperative)
  • DescriptionCosmetic Discomfort Score (Using EuraHS-QoL): how it is measured was reworded
  • DescriptionPain Score at the Hernia Side (Using EuraHS-QoL): how it is measured was reworded
  • DescriptionScore for Activity Limitation Due to Pain or Discomfort (Using EuraHS-QoL): how it is measured was reworded
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Recruiting→Completed
    Start date Apr 20, 2024→May 1, 2024
    Primary completion Apr 30, 2025→Jul 3, 2026 (now actual)
    Study completion Apr 20, 2026→Jul 3, 2026 (now actual)
    Enrollment 106 (estimated)→90 (actual)
    Secondary outcomes 4 time frame changed, 3 description edited
    What changed in the outcomes
    • Time frameDuration of Operation (in minutes)Per-operation → During the index operation (intraoperative)
    • Time frameBlood Loss During Operation (in milliliters)Per-operation → During the index operation (intraoperative)
    • Time frameNumber of Tackers Used During OperationPer-operation → During the index operation (intraoperative)
    • Time frameMesh Size Used in Operation (in square centimeters)Per-operation → During the index operation (intraoperative)
    • DescriptionCosmetic Discomfort Score (Using EuraHS-QoL): how it is measured was reworded
    • DescriptionPain Score at the Hernia Side (Using EuraHS-QoL): how it is measured was reworded
    • DescriptionScore for Activity Limitation Due to Pain or Discomfort (Using EuraHS-QoL): how it is measured was reworded
    Interventions Added Device: Polypropylene mesh
    + 8 other changes: identifiers, verification date, responsible party, oversight details, description, design details, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06786702
Lead sponsor
Muhammet Mustafa Vural
Responsible party
Muhammet Mustafa Vural (M.D., Department of General Surgery, Başakşehir Çam & Sakura City Hospital) — Sponsor-investigator
First posted
Jan 22, 2025
Start date
May 1, 2024
Primary completion
Jul 3, 2026
Completion
Jul 3, 2026
Last update
Nov 17, 2026

Study contacts

Muhammet M. Vural, M.D
principal investigator · Basakşehir Çam Sakura Şehir Hastanesi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion